Active	Status	Sponsor type	Region	Phase	Filter
18 Active 0 Inactive 18 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
zhao, hongru
NCT04649242 / 2020-003517-35: Randomized Study in Children and Adolescents With Migraine: Acute Treatment	Recruiting	3	2100	Europe, Canada, Japan, US, RoW	Rimegepant/BHV3000, Matching placebo	Pfizer	Pediatric Migraine	01/29	01/29
Xue, Sheng-Li
NCT03064269: CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia	Recruiting	1	10	RoW	CD19 CAR-T cells	Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd, The First Affiliated Hospital of Soochow University	B-cell Acute Lymphocytic Leukemia	12/24	12/25
NCT05772273: PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT	Recruiting	N/A	43	RoW	Azacitidine, Donor lymphocyte infusion, Camrelizumab	The First Affiliated Hospital of Soochow University, Jiangsu HengRui Medicine Co., Ltd.	Acute Myeloid Leukemia	07/25	12/25